First-in- class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients (pts) with advanced solid tumors: First-in-human phase I study

被引:0
作者
Bai, X. [1 ]
Chen, Y. [1 ,2 ,3 ,4 ]
Chen, Y. [1 ,2 ,3 ,4 ]
Liang, X. [5 ]
Wang, H. [6 ]
Sun, Y.
Chu, Q. [7 ]
Pan, Y. [8 ]
Cui, J. [9 ]
Fang, J. [10 ]
Zhang, W. [11 ]
Xu, Q. [12 ]
Zhang, J. [13 ]
Liu, X. [14 ]
Dai, G. [14 ]
Kang, L. [15 ]
Li, N. [16 ]
Fang, M. [17 ]
Zhou, H. [18 ]
Liang, T. [1 ]
机构
[1] Zhejiang Univ, Hepatopancreatobiliary Surg, Affiliated Hosp 1, Med Sch, Hangzhou, Peoples R China
[2] Fujian Canc Hosp, VIP Ward, Fuzhou, Peoples R China
[3] Fujian Canc Hosp, Dept Clin Nutr, Fuzhou, Peoples R China
[4] Fujian Canc Hosp, Canc Bioimmunotherapy Ctr, Fuzhou, Peoples R China
[5] Hubei Canc Hosp, Abdominal Med, Wuhan, Peoples R China
[6] Hunan Canc Hosp, Chest Radiotherapy Dept 1, Changsha, Peoples R China
[7] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Tongji Med Coll, Wuhan, Peoples R China
[8] Anhui Prov Hosp, Med Oncol, Hefei, Peoples R China
[9] First Hosp Jilin Univ, Oncol, Changchun, Peoples R China
[10] Peking Univ, Second Dept Thorac Tumors, Canc Hosp, Beijing, Peoples R China
[11] Third Peoples Hosp Zhengzhou, Dept Melanoma Oncol, Zhengzhou, Peoples R China
[12] Fujian Prov Canc Hosp, Gyn Surg Oncol, Fuzhou, Peoples R China
[13] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China
[14] Peoples Liberat Army Gen Hosp, Oncol, Med Ctr 5, Beijing, Peoples R China
[15] SYSU, Colorectal Surg, Affiliated Hosp 6, Guangzhou, Peoples R China
[16] Chinese Acad Med Sci & Peking Union Med Coll, Dept Thorac Surg, Natl Canc Ctr, Canc Hosp, Beijing, Peoples R China
[17] Univ Chinese Acad Sci, Dept Head & Neck & Rare Oncol, Chinese Acad Sci, Canc Hosp, Hangzhou, Peoples R China
[18] Innovent Biol Inc, Clin Dev, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
VP4-2024
引用
收藏
页码:681 / 682
页数:2
相关论文
empty
未找到相关数据